Prestige Honors Performance: UHealth CEO Dipen Parekh, M.D., Awarded Barringer Medal for Distinguished Career and Future Impact
The American Association of Genitourinary Surgeons honors Dipen J. Parekh, M.D., for a distinguished career in urologic cancer treatment and a forward-looking vision that includes pioneering work in artificial intelligence-driven surgery.
Among the most selective honors in academic urology, the Barringer Medal recognizes both achievement and trajectory, that rare combination of sustained excellence and the expectation of continued impact.
This year, Dipen J. Parekh, M.D., chief executive officer of UHealth — University of Miami Health System, founding director of the Desai Sethi Urology Institute (DSUI) and a nationally recognized urologic surgeon, was named the recipient. The honor underscored his global reputation and his forward-looking vision for the field.
Presented by the American Association of Genitourinary Surgeons (AAGUS), the Barringer Medal reflects the highest level of peer recognition within a society composed of just 75 active members worldwide. Inclusion in the society is by member nomination only, representing leading academic urologists from the all over the world. From this already-elite group, Barringer honorees are selected for distinguished accomplishments, particularly in the study and treatment of genitourinary disease.
“Receiving the Barringer Medal is a tremendous honor, particularly from a society that represents the very best in academic urology worldwide,” said Dr. Parekh who is also the executive vice president for health affairs at the University of Miami and the Magnier Endowed Chair in Urology at the University of Miami Miller School of Medicine. “I accept this honor on behalf of the Desai Sethi Urology Institute, the University of Miami Health System and the Miller School of Medicine, whose collective commitment to advancing medicine and patient care makes achievements like this possible. At my core, I remain an active physician and surgeon dedicated to improving the health of my patients. This award is both humbling and deeply motivating as we continue to push the boundaries of research, innovation and patient care.”
“The Barringer Award is generally given to a person who is expected to continue those achievements throughout their career,” said Alan J. Wein, M.D., Ph.D. (hon.), professor of clinical urology at the Miller School and director of business development and mentoring for DSUI. “It’s a big deal.”
The emphasis on future contributions is central to the distinction. The award is reserved for members younger than 60, reinforcing its role as both a recognition of sustained accomplishment and a signal of continued leadership.
As Dr. Wein, an AAGUS leader and past award recipient, noted, “The Barringer Award is really given to someone who is expected to push the field forward.”
Over the course of his career, Dr. Parekh has built an international reputation for advancing the treatment of urologic cancers, combining surgical innovation with translational research. As the director of robotic surgery for the health system, Dr. Parekh has performed more than 6,000 robotic urologic procedures. He was the principal investigator of the influential RAZOR clinical trial, the first to evaluate the effectiveness of a robotic approach in bladder cancer. His work has influenced both clinical practice and academic scholarship, positioning him among the most respected voices in urologic surgery.
That blend of clinical excellence and technological vision was on full display at the AAGUS annual meeting, where Dr. Parekh delivered a widely discussed presentation on the future of artificial intelligence in the surgical field. Selected as one of just 36 presentations accepted for the meeting, the talk stood apart from the award yet reinforced the qualities that define it.
Dr. Parekh’s work presented the launching of the first AI surgical agent that incorporates real-time verbal input, using artificial intelligence to generate an immediate, precise operative record. The implications extend well beyond documentation. This real-time data capture and analysis enhances surgical training, enables performance review and guides intraoperative decision-making.
“Artificial intelligence will play an increasingly important role in surgery as a powerful tool to enhance precision, improve documentation and, ultimately, elevate patient care in real time,” Dr. Parekh said.
The presentation also reflected a broader institutional trajectory. Under Dr. Parekh’s leadership, UHealth is emerging as a center for integrating artificial intelligence into clinical care and surgical practice.
“Dr. Parekh and the University of Miami are going to be extremely well-known as one of the centers that has pioneered the use of artificial intelligence,” Dr. Wein said.
On its website, the AAGUS stresses to medal awardees the importance of not letting the award “lie fallow.” Within this context, the Barringer Medal serves as both milestone and mandate, honoring a career defined by excellence while anticipating continued innovation. For Dr. Parekh, the recognition affirms not just what has been achieved, but what lies ahead.
The University of Miami is leading the BEAT-MS trial, studying stem cell transplantation as a potential treatment for multiple sclerosis.
Dr. Dipen J. Parekh, CEO of UHealth and executive vice president at the University of Miami, was elected to the Research!America Board of Directors.
Tags: AI, artificial intelligence, bladder cancer, Department of Urology, Desai Sethi Urology Institute, Dr. Dipen Parekh, robotic surgery, technology, urology